This includes preventing or reducing the side effects of cancer chemotherapy, especially Oral Mucositis (OM).
PBM is so successful, it is now the recommended standard of care among oncologists worldwide. Leading Cancer Centers, including Saint Jude and the University of Pittsburgh Medical Center (UPMC), have incorporated PBM into their Standard Order Sets.
Numerous BCBS affiliates reimburses PBM treatments for OM as “medically necessary”.
Britain’s National Health Program covers PBM treatments for OM.
Pilot studies are being initiated for using PBM to prevent Acute Respiratory Distress Syndrome (ARDS), the leading cause of death from COVID-19.
The FDA has authorized clinical trials for using PBM to reverse the effects of Dry Age-Related Macular Degeneration.